[Recommendations of the German Society of Rheumatology on therapy of pulmonary hypertension in patients with autoimmune diseases].
Schulze-Koops
H
H
Klinische Forschergruppe III, Nikolaus-Fiebiger-Zentrum für Molekulare Medizin, Glückstrasse 6, 91054 Erlangen. Schulze-Koops@med3.imed.uni-erlangen.de
D000465:Algorithms; D004359:Drug Therapy, Combination; D065128:Endothelin Receptor Antagonists; D019317:Evidence-Based Medicine; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D044062:Prostaglandins I / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D012219:Rheumatology; D012955:Societies, Medical; D014665:Vasodilator Agents / Q000627:therapeutic use*
D065128:Endothelin Receptor Antagonists; D010726:Phosphodiesterase Inhibitors; D044062:Prostaglandins I; D014665:Vasodilator Agents